Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (246)
- Medicines safety (146)
- COVID-19 (144)
- Prescription medicines (129)
- Regulatory compliance (120)
- COVID-19 vaccines (88)
- Legislation (78)
- Therapeutic goods regulation (71)
- Listed medicines (48)
- Non-prescription medicines (43)
- Medical devices safety (42)
- Safety (40)
- Vaping hub (33)
- Complementary medicines (30)
- Manufacturing (28)
- Labelling and packaging (25)
- Assessed listed medicines (24)
- Scheduling (national classification system) (23)
- Over the counter (OTC) medicines (21)
- Compliance and enforcement hub (20)
- Medicinal cannabis hub (20)
- Import and export (19)
- Australian Register of Therapeutic Goods (ARTG) (17)
- Alert/Advisory (12)
- Shortages (12)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Sunscreens (6)
- Weight loss products (6)
- Advisory bodies and committees (5)
- Cosmetics (3)
- Blood and blood components (2)
- Clinical trials (2)
- Fees and payments (2)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Blood safety (1)
- Breast implant hub (1)
- Registered complementary medicines (1)
- Travelling with health products (1)
Results for
"[search-keyword]"
Search
1055 result(s) found, displaying 301 to 325
-
Media releasesDirection and infringement notices given to MDNE Enterprises Pty Ltd for alleged unlawful advertising of nicotine vaping products
-
Media releasesFines totalling $972,360 given to three medicinal cannabis companies for alleged unlawful advertising
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesJSHealth Vitamins Pty Ltd fined for alleged unlawful advertising
-
Media releasesThe TGA has provisionally approved Pfizer's COVID-19 vaccine, COMIRNATY (tozinameran) for use as a booster dose in individuals 5 years to 11 years.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Media releasesThe TGA has published an independent expert report examining the incidence of serious injury and death from intentional paracetamol overdose.
-
Safety updatesMedicines safety update - Information for health professionals
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has approved the first two nasal combination self-tests (for use at home) that detect both COVID-19 and influenza viral infections in humans.
-
Media releasesTGA approves asciminib and faricimab through the Access New Active Substance Work-Sharing Initiative
-
Media releasesThe TGA has issued 7 infringement notices totalling $93,240 to Cyclotek Queensland Pty Ltd
-
Media releasesWA-based company World Environmental Technologies Pty Ltd fined $13,320 for alleged unlawful importation of ivermectin, a prescription-only medicine.
-
Media releasesTGA provisionally approves Moderna bivalent COVID-19 vaccine for use as a booster dose in adults
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
NoticesUpdate to the manufacturing principles for medicinal products
-
Media releasesVictoria-based Doughbot Enterprises fined $87,312 and undertakes to comply with advertising rules for nicotine vaping products.
-
Compliance undertakingsDoughbot Enterprises and its sole director have accepted an enforceable undertaking to not advertise nicotine vaping products or support their advertising.
-
Media releasesTGA's participation in INTERPOL's Operation Pangea, which tackles the trade of illicit and counterfeit therapeutic goods worldwide, led to intercepting more than $2 million of illegally imported products.
-
NewsTGA SME Assist presents "Meeting your Obligations" a free workshop aimed at beginners who are unfamiliar with therapeutic goods regulation.
-
Media releasesTGA grants provisional determination for sabizabulin for the treatment of COVID-19
-
NoticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
NoticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
NoticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
NewsThe TGA approved Moderna Australia’s application to transition its COVID-19 vaccine, SPIKEVAX (elasomeran), from provisional to full registration.